These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31821536)

  • 1. Cell transformation by the adenovirus oncogenes E1 and E4.
    Ip WH; Dobner T
    FEBS Lett; 2020 Jun; 594(12):1848-1860. PubMed ID: 31821536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell transformation by human adenoviruses.
    Endter C; Dobner T
    Curr Top Microbiol Immunol; 2004; 273():163-214. PubMed ID: 14674602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus type 5 early encoded proteins of the E1 and E4 regions induce oncogenic transformation of primary rabbit cells.
    Wimmer P; Täuber B; Spruss T; Dobner T
    J Gen Virol; 2010 Jul; 91(Pt 7):1828-33. PubMed ID: 20335490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Hit-and-run" transformation by adenovirus oncogenes.
    Nevels M; Täuber B; Spruss T; Wolf H; Dobner T
    J Virol; 2001 Apr; 75(7):3089-94. PubMed ID: 11238835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early region 1 transforming functions are dispensable for mammary tumorigenesis by human adenovirus type 9.
    Thomas DL; Shin S; Jiang BH; Vogel H; Ross MA; Kaplitt M; Shenk TE; Javier RT
    J Virol; 1999 Apr; 73(4):3071-9. PubMed ID: 10074157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus early E4 genes in viral oncogenesis.
    Täuber B; Dobner T
    Oncogene; 2001 Nov; 20(54):7847-54. PubMed ID: 11753667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
    Krougliak V; Graham FL
    Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
    Nevels M; Spruss T; Wolf H; Dobner T
    Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming potential of the adenovirus type 5 E4orf3 protein.
    Nevels M; Täuber B; Kremmer E; Spruss T; Wolf H; Dobner T
    J Virol; 1999 Feb; 73(2):1591-600. PubMed ID: 9882365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.
    Yeh P; Dedieu JF; Orsini C; Vigne E; Denefle P; Perricaudet M
    J Virol; 1996 Jan; 70(1):559-65. PubMed ID: 8523570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
    Hoffmann D; Wildner O
    BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53.
    DeHart CJ; Perlman DH; Flint SJ
    J Virol; 2015 Mar; 89(6):3209-20. PubMed ID: 25568206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic potential of the adenovirus E4orf6 protein.
    Moore M; Horikoshi N; Shenk T
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11295-301. PubMed ID: 8876129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of a potential zinc-binding domain of the adenovirus E4 34k protein.
    Boyer JL; Ketner G
    J Biol Chem; 2000 May; 275(20):14969-78. PubMed ID: 10747932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation.
    Baker A; Rohleder KJ; Hanakahi LA; Ketner G
    J Virol; 2007 Jul; 81(13):7034-40. PubMed ID: 17459921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the transforming activities of adenovirus oncogenes.
    Nevels M; Dobner T
    Methods Mol Med; 2007; 131():187-95. PubMed ID: 17656783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors.
    Mizuguchi H; Kay MA
    Hum Gene Ther; 1999 Aug; 10(12):2013-7. PubMed ID: 10466635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
    Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I
    J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function.
    Nevels M; Rubenwolf S; Spruss T; Wolf H; Dobner T
    Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1206-11. PubMed ID: 9037031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.